Effect of active anticancer therapy on serologic response to SARS‐CoV‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma-Reference-Cited by-同舟云学术

Effect of active anticancer therapy on serologic response to SARS‐CoV‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma

Published:2022-03-31 Issue:7 Volume:29 Page:733-739
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J of Urology

Author:

Togashi Kyo¹,Hatakeyama Shingo²^ORCID,Yoneyama Tohru³,Hamaya Tomoko¹,Narita Takuma¹^ORCID,Fujita Naoki¹,Iwamura Hiromichi¹^ORCID,Okamoto Teppei¹,Yamamoto Hayato¹,Yoneyama Takahiro⁴,Hashimoto Yasuhiro¹,Ohyama Chikara¹²³

Affiliation:

1. Department of Urology Hirosaki University School of Medicine Hirosaki Aomori Japan

2. Department of Advanced Blood Purification Therapy Hirosaki University School of Medicine Hirosaki Aomori Japan

3. Department of Glycotechnology, Center for Advanced Medical Research Hirosaki University School of Medicine Hirosaki Aomori Japan

4. Department of Advanced Transplant and Regenerative Medicine Hirosaki University School of Medicine Hirosaki Aomori Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14882

Reference29 articles.

1. Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection

2. Seroconversion rates following COVID-19 vaccination among patients with cancer

3. Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

4. Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer

5. Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the coronavirus disease 2019 pandemic on the number of undergoing radical nephroureterectomy and postoperative adjuvant systematic therapy for upper tract urothelial carcinomas in Japan: A multicenter retrospective study;International Journal of Urology;2023-02-06

2. Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids;Urologic Oncology: Seminars and Original Investigations;2022-10

3. Editorial Comment from Dr Yuasa to Effect of active anticancer therapy on serologic response to SARS‐CoV ‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma;International Journal of Urology;2022-05-10

4. Editorial Comment from Dr Kobayashi to Effect of active anticancer therapy on serologic response to SARS‐CoV‐2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma;International Journal of Urology;2022-04-27